FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffrey Green

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

Physiology

Co-author Network

Publications

TOP 3
Elisa Paolicchi; Francesco Crea; William L Farrar; Jeffrey E Green; Romano Danesi
Histone lysine demethylases in breast cancer.
Isabel M Chu; Lara H El Touny; Hosein Kouros-Mehr; Wei-Chu Lai; Olga Aprelikova; Jeffrey E Green
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß.
Tamaro S Hudson; William J Muller; Lorraine Sordillo; Heather A Young; Bradley A Carlson; Dolph L Hatfield; Mark J Hoeneroff; Jeffrey E Green
Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffrey Green (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elisa Paolicchi; Francesco Crea; William L Farrar; Jeffrey E Green; Romano Danesi
Histone lysine demethylases in breast cancer.
Critical reviews in oncology/hematology 2013;86(2):97-103.
2013: Isabel M Chu; Lara H El Touny; Hosein Kouros-Mehr; Wei-Chu Lai; Olga Aprelikova; Jeffrey E Green
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß.
PloS one 2013;8(4):e61125.
2012: Tamaro S Hudson; William J Muller; Lorraine Sordillo; Heather A Young; Bradley A Carlson; Dolph L Hatfield; Mark J Hoeneroff; Jeffrey E Green
Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis.
Carcinogenesis 2012;33(6):1225-30.
2012: I M Chu; Katalin Csiszar; K Flanders; Mark Hoenerhoff; D Luger; A M Michalowski; A Oshima; M Sato; Kornelia Molnarne Szauter; Jeffrey E Green
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
Oncogene 2012;31(16):2017-27.
2012: Olga Aprelikova; Jeffrey E Green
MicroRNA regulation in cancer-associated fibroblasts.
Cancer immunology, immunotherapy : CII 2012;61(2):231-7.
2011: Mark J Hoenerhoff; M A Shibata; A Bode; Jeffrey E Green
Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
Transgenic research 2011;20(2):247-59.
2011: Chang Hee Kim; Hark K Kim; Joseph Kim; Eunbyul T Lee; David J Munroe; R Luke Rettig; Olga Aprelikova; Il J Choi; Jeffrey E Green
miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
BMC medical genomics 2011;4():79.
2011: Min Zhu; Chuxia Deng; Chang Hee Kim; Yi Li; Daniel Medina; Robert M Stephens; Ming Yi; Jeffrey E Green
Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Genome biology 2011;12(8):R77.
2011: Hark Kyun Kim; Joseph Kim; Susie Korolevich; David J Munroe; Il Ju Choi; Chang Hee Kim; Jeffrey E Green
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection.
BMC medical genomics 2011;4():48.
2011: Hark Kyun Kim; Il Ju Choi; Chan Gyoo Kim; Hee Sung Kim; Akira Oshima; Aleksandra Michalowski; Jeffrey E Green
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
PloS one 2011;6(2):e16694.
2010: Bing Liu; Lin Liu; Anna Tsykin; Gregory J Goodall; Jeffrey E Green; Min Zhu; Chang Hee Kim; Jiuyong Li
Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation.
Bioinformatics (Oxford, England) 2010;26(24):3105-11.
2010: Hark Kyun Kim; Michelle L Reyzer; Il Ju Choi; Chan Gyoo Kim; Hee Sung Kim; Akira Oshima; Oleg Chertov; Simona Colantonio; Robert J Fisher; Jamie L Allen; Richard M Caprioli; Jeffrey E Green
Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry.
Journal of proteome research 2010;9(8):4123-30.
2010: Alfonso Calvo; Carlos Perez-Stable; Victor Segura; Raúl Catena; Elizabeth Guruceaga; Paul Nguewa; David Blanco; Luis Parada; Teresita Reiner; Jeffrey E Green
Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.
The Prostate 2010;70(6):630-45.
2010: Oscar Gonzalez-Moreno; Jon Lecanda; Jeffrey E Green; Victor Segura; Raul Catena; Diego Serrano; Alfonso Calvo
VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.
Experimental cell research 2010;316(4):554-67.
2010: Christina N Bennett; Jeffrey E Green
Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer.
Toxicologic pathology 2010;38(1):88-95.
2009: Mark J Hoenerhoff; I Chu; D Barkan; Z-y Liu; S Datta; G P Dimri; Jeffrey E Green
BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
Oncogene 2009;28(34):3022-32.
2008: Bharat H Joshi; Pamela Leland; Alfonso Calvo; Jeffrey E Green; Raj K Puri
Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.
Cancer research 2008;68(22):9311-7.
2008: Alfonso Calvo; Raul Catena; M S Noble; D Carbott; I Gil-Bazo; Oscar Gonzalez-Moreno; Jung-Im Huh; Richard Sharp; T-H Qiu; Miriam R Anver; Glenn Merlino; Robert B Dickson; M D Johnson; Jeffrey E Green
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
Oncogene 2008;27(40):5373-84.
2008: Cory Abate-Shen; Powel H Brown; Nancy H Colburn; Eugene W Gerner; Jeffrey E Green; Martin Lipkin; William G Nelson; David Threadgill
The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges.
Cancer prevention research (Philadelphia, Pa.) 2008;1(3):161-6.
2008: Dalit Barkan; Hynda Kleinman; Justin L Simmons; Holly Asmussen; Anil K Kamaraju; Mark J Hoenorhoff; Zi-yao Liu; Sylvain V Costes; Edward Cho; Stephen Lockett; Chand Khanna; Ann F Chambers; Jeffrey E Green
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
Cancer research 2008;68(15):6241-50.
2008: Mei Zhang; Fariba Behbod; Rachel L Atkinson; Melissa D Landis; Frances S Kittrell; David Edwards; Daniel Medina; Anna Tsimelzon; Susan G Hilsenbeck; Jeffrey E Green; Aleksandra M Michalowska; Jeffrey M Rosen
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Cancer research 2008;68(12):4674-82.
2008: Shoichiro Ohta; Edwin W Lai; John C Morris; Alan Pang; Morihiro Watanabe; Hiroshi Yazawa; Richard Zhang; Jeffrey E Green; Wai-Yee Chan; Paul Sirajuddin; Shun'ichiro Taniguchi; James F Powers; Arthur S Tischler; Karel Pacak
Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells.
Molecular carcinogenesis 2008;47(4):245-51.
2008: Christina N Bennett; Jeffrey E Green
Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models.
Breast cancer research : BCR 2008;10(5):213.
2007: Sonal Datta; Mark J Hoenerhoff; Prashant Bommi; Rachana Sainger; Wei-Jian Guo; Manjari Dimri; Hamid Band; Vimla Band; Jeffrey E Green; Goberdhan P Dimri
Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.
Cancer research 2007;67(21):10286-95.
2007: Tamaro S Hudson; Diane K Hartle; Stephen D Hursting; Nomeli P Nunez; Thomas T Y Wang; Heather A Young; Praveen Arany; Jeffrey E Green
Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
Cancer research 2007;67(17):8396-405.
2007: Kristin K Deeb; Aleksandra M Michalowska; Cheol-Yong Yoon; Scott M Krummey; Mark J Hoenerhoff; Claudine Kavanaugh; Ming-Chung Li; Francesco J DeMayo; Ilona Linnoila; Chu-Xia Deng; Eva Y-H P Lee; Daniel Medina; Joanna H Shih; Jeffrey E Green
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Cancer research 2007;67(17):8065-80.
2007: Raul Catena; Muniz-Medina Vanessa; Beatriz Moralejo; Biola Javierre; Carolyn J M Best; Michael R Emmert-Buck; Jeffrey E Green; Carl Baker; Alfonso Calvo
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis.
International journal of cancer. Journal international du cancer 2007;120(10):2096-109.
2007: Lyuba Varticovski; Melinda G Hollingshead; Ana I Robles; Xiaolin Wu; James Cherry; David J Munroe; Luanne Lukes; Miriam R Anver; John P Carter; Suzanne D Borgel; Howard Stotler; Carrie A Bonomi; Nomeli P Nunez; Stephen D Hursting; Wenhui Qiao; Chuxia X Deng; Jeffrey E Green; Kent W Hunter; Glenn Merlino; Patricia S Steeg; Lalage M Wakefield; J Carl Barrett
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2168-77.
2007: Jung-Im Huh; Ting Hu Qiu; Gadisetti V R Chandramouli; Rhonda Charles; Malgorzata Wiench; Gordon L Hager; Raul Catena; Alfonso Calvo; Theresa M Lavallee; Pierre-Yves Desprez; Jeffrey E Green
2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice.
Endocrinology 2007;148(3):1266-77.
2007: Samantha Oakes; Fiona G Robertson; James G Kench; Margaret Gardiner-Garden; M P Wand; Jeffrey E Green; Christopher J Ormandy
Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions.
Oncogene 2007;26(4):543-53.
2007: Alexander N Shoushtari; Aleksandra M Michalowska; Jeffrey E Green
Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling.
Breast disease 2007;28():39-51.
2007: Jason Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette Knight Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary Churchill; Terry Van Dyke; Charles M Perou
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Genome biology 2007;8(5):R76.
2006: Jung-Im Huh; Alfonso Calvo; Rhonda Charles; Jeffrey E Green
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.
Cancer research 2006;66(7):3495-503.
2005: Zhuohua Wang; Gail S Prins; Karen T Coschigano; John J Kopchick; Jeffrey E Green; Vera H Ray; Samad Hedayat; Konstantin Christov-Tzelkov; Terry G Unterman; Steven M Swanson
Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.
Endocrinology 2005;146(12):5188-96.
2005: Chia-Ling Hsieh; Zhihui Xie; Zhi-Ren Liu; Jeffrey E Green; W David Martin; Milton W Datta; Fan Yeung; D Pan; Leland W K Chung
A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals.
Journal of molecular endocrinology 2005;35(2):293-304.
2005: Alfonso Calvo; Oscar Gonzalez-Moreno; Cheol-Yong Yoon; Jung-Im Huh; Kartiki Desai; Quang Tri Nguyen; Jeffrey E Green
Prostate cancer and the genomic revolution: Advances using microarray analyses.
Mutation research 2005;576(1-2):66-79.
2005: Oscar Gonzalez-Moreno; Alfonso Calvo; Bharat H Joshi; Ibane Abasolo; Pamela Leland; Zhou Wang; Luis M Montuenga; Raj K Puri; Jeffrey E Green
Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin.
International journal of cancer. Journal international du cancer 2005;114(6):870-8.
2005: Jeffrey E Green; Tamaro Hudson
The promise of genetically engineered mice for cancer prevention studies.
Nature reviews. Cancer 2005;5(3):184-98.
2005: Vandana Gupta; Jennifer L Carey; Hirofumi Kawakubo; Alona Muzikansky; Jeffrey E Green; Patricia K Donahoe; David T MacLaughlin; Shyamala Maheswaran
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(9):3219-24.
2005: Jung-Im Huh; Alfonso Calvo; Jeffrey Stafford; Mui Cheung; Rakesh Kumar; Deborah Philp; Hynda K Kleinman; Jeffrey E Green
Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Oncogene 2005;24(5):790-800.
2005: Shixia Huang; Yi Li; Yidong Chen; Katrina Podsypanina; Mario Chamorro; Adam B Olshen; Kartiki V Desai; Anne Tann; David Petersen; Jeffrey E Green; Harold Varmus
Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Genome biology 2005;6(10):R84.
2005: David Petersen; Gadisetti V R Chandramouli; Joel Geoghegan; Joanne Hilburn; Jonathon Paarlberg; Chang Hee Kim; David J Munroe; Lisa Gangi; Jing Han; Raj Puri; Lou Staudt; John Weinstein; J Carl Barrett; Jeffrey E Green; Ernest S Kawasaki
Three microarray platforms: an analysis of their concordance in profiling gene expression.
BMC genomics 2005;6():63.
2004: Joanna H Shih; Aleksandra M Michalowska; Kevin Dobbin; Yumei Ye; Ting Hu Qiu; Jeffrey E Green
Effects of pooling mRNA in microarray class comparisons.
Bioinformatics (Oxford, England) 2004;20(18):3318-25.
2004: Kartiki V Desai; Aleksandra M Michalowska; Paturu Kondaiah; Jerrold M Ward; Joanna H Shih; Jeffrey E Green
Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate.
Molecular endocrinology (Baltimore, Md.) 2004;18(12):2895-907.
2004: Hirofumi Kawakubo; Jennifer L Carey; Elena F Brachtel; Vandana Gupta; Jeffrey E Green; Paul D Walden; Shyamala Maheswaran
Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.
Oncogene 2004;23(50):8310-9.
2004: Ahmad Utomo; Xianzhi Jiang; Saori Furuta; Jeanho Yun; David S Levin; Yi-Chun J Wang; Kartiki V Desai; Jeffrey E Green; Phang-Lang Chen; Wen-Hwa Lee
Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells.
The Journal of biological chemistry 2004;279(42):43522-9.
2004: Ting Hu Qiu; Gadisetti V R Chandramouli; Kent W Hunter; Nawal W Alkharouf; Jeffrey E Green; Edison Liu
Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Cancer research 2004;64(17):5973-81.
2004: Jeffrey E Green; Kartiki V Desai; Yumei Ye; Claudine Kavanaugh; Alfonso Calvo; Jung-Im Huh
Application of gene expression profiling for validating models of human breast cancer.
Toxicologic pathology 2004;32 Suppl 1():84-9.
2004: Terry W Moody; James Dudek; Halina Zakowicz; James Walters; Robert T Jensen; Emmanual Petricoin; Christine Couldrey; Jeffrey E Green
VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice.
Life sciences 2004;74(11):1345-57.
2004: Yumei Ye; Ting Hu Qiu; Claudine Kavanaugh; Jeffrey E Green
Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling.
Breast disease 2004;19():69-82.
2004: Jeffrey E Green; Kartiki Desai; Yumei Ye; Claudine Kavanaugh; Alfonso Calvo; Jung-Im Huh
Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 2):385S-90S.
2004: Steven E Come; Aman U Buzdar; Carlos L Arteaga; Mina J Bissell; Myles Brown; Matthew J Ellis; Paul E Goss; Jeffrey E Green; James N Ingle; Adrian V Lee; Daniel Medina; Robert I Nicholson; Richard J Santen; Rachel Schiff; Carol S Hart
Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 2):327S-330S.
2003: Yiping Wu; Karen Cui; Keiko Miyoshi; Lothar Hennighausen; Jeffrey E Green; Jennifer Setser; Derek LeRoith; Shoshana Yakar
Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
Cancer research 2003;63(15):4384-8.
2003: Stanislaw J Kaczmarczyk; Jeffrey E Green
Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions.
Nucleic acids research 2003;31(15):e86.
2003: Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Interrogating mouse mammary cancer models: insights from gene expression profiling.
Journal of mammary gland biology and neoplasia 2003;8(3):321-34.
2003: Claudine Kavanaugh; Jeffrey E Green
The use of genetically altered mice for breast cancer prevention studies.
The Journal of nutrition 2003;133(7 Suppl):2404S-2409S.
2003: Carolyn J M Best; Isabel M Leiva; Rodrigo F Chuaqui; John W Gillespie; Paul H Duray; Meera Murgai; Yingdong Zhao; Richard Simon; Jason J Kang; Jeffrey E Green; David G Bostwick; W Marston Linehan; Michael R Emmert-Buck
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2003;12(2):63-70.
2003: Masa-Aki Shibata; Claudine Kavanaugh; Eiko Shibata; Hideaki Abe; Phuongmai Nguyen; Yoshinori Otsuki; Jane Trepel; Jeffrey E Green
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.
Carcinogenesis 2003;24(3):453-9.
2003: Ryan G Holzer; Christina MacDougall; Gerry Cortright; Kristi Atwood; Jeffrey E Green; Cheryl Jorcyk
Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model.
Breast cancer research and treatment 2003;77(1):65-76.
2002: Kartiki V Desai; Claudine Kavanaugh; Alfonso Calvo; Jeffrey E Green
Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer.
Endocrine-related cancer 2002;9(4):207-20.
2002: Jeffrey E Green; Robert Cardiff; Lothar Hennighausen; Lalage M Wakefield; Ulrike Wagner; Eva Lee; Jeffrey Rosen; Daniel Medina; Alexander Nitkin; Edison Liu
Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM.
Transgenic research 2002;11(6):635-6.
2002: Claudine Kavanaugh; Kartiki V Desai; Alfonso Calvo; P H Brown; Christine Couldrey; Ronald A Lubet; Jeffrey E Green
Pre-clinical applications of transgenic mouse mammary cancer models.
Transgenic research 2002;11(6):617-33.
2002: Alfonso Calvo; Yumi Yokoyama; Lois E H Smith; Iqbal Ali; Shu-Ching Shih; Andrew L Feldman; Steven Libutti; Ramakrishnan Sundaram; Jeffrey E Green
Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
International journal of cancer. Journal international du cancer 2002;101(3):224-34.
2002: Alfonso Calvo; Nianqing Xiao; Jason Kang; Carolyn J M Best; Isabel M Leiva; Michael R Emmert-Buck; Cheryl Jorcyk; Jeffrey E Green
Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Cancer research 2002;62(18):5325-35.
2002: Alfonso Calvo; Andrew L Feldman; Steven Libutti; Jeffrey E Green
Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.
Cancer research 2002;62(14):3934-8.
2002: Shu-Ching Shih; Gregory S Robinson; Carole A Perruzzi; Alfonso Calvo; Kartiki Desai; Jeffrey E Green; Iqbal Unnisa Ali; Lois E H Smith; Donald R Senger
Molecular profiling of angiogenesis markers.
The American journal of pathology 2002;161(1):35-41.
2002: Yu-An Yang; Oksana Dukhanina; Binwu Tang; Mizuko Mamura; John J Letterio; Jennifer MacGregor; Sejal C Patel; Shahram Khozin; Zi-Yao Liu; Jeffrey E Green; Miriam R Anver; Glenn Merlino; Lalage M Wakefield
Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.
The Journal of clinical investigation 2002;109(12):1607-15.
2002: Kartiki V Desai; Nianqing Xiao; Weili Wang; Lisa Gangi; John Greene; John I Powell; Robert Dickson; Priscilla A Furth; Kent Hunter; Raju Kucherlapati; Richard Simon; Edison Liu; Jeffrey E Green
Initiating oncogenic event determines gene-expression patterns of human breast cancer models.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6967-72.
2002: Kendall Wu; Heung Tae Kim; Jenny L Rodriquez; Susan G Hilsenbeck; Syed K Mohsin; Xiao-Chun Xu; William W Lamph; John Kuhn; Jeffrey E Green; Powel H Brown
Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(5):467-74.
2002: Christine Couldrey; Jaideep Moitra; Charles Vinson; Miriam R Anver; Kunio Nagashima; Jeffrey E Green
Adipose tissue: a vital in vivo role in mammary gland development but not differentiation.
Developmental dynamics : an official publication of the American Association of Anatomists 2002;223(4):459-68.
2002: Judith A Wubah; Carolyn M Fischer; Laura N Rolfzen; May Khalili; Jason Kang; Jeffrey E Green; Charles J Bieberich
Ventral prostate predominant l, a novel mouse gene expressed exclusively in the prostate.
The Prostate 2002;51(1):21-9.
2002: Colin R Soares; Masa-Aki Shibata; Jeffrey E Green; Cheryl Jorcyk
Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression.
Neoplasia (New York, N.Y.) 2002;4(2):112-20.
2001: Jeffrey E Green; MA Shibata; E Shibata; R C Moon; Miriam R Anver; Gary J Kelloff; Ronald A Lubet
2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Cancer research 2001;61(20):7449-55.
2001: Ki-Baik Hahm; YH Im; T W Parks; Seok Hee Park; S Markowitz; H Y Jung; Jeffrey E Green; Seong-Jin Kim
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.
Gut 2001;49(2):190-8.
2001: Stanislaw J Kaczmarczyk; Jeffrey E Green
A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression.
Nucleic acids research 2001;29(12):E56-6.
2001: ML Liu; MA Shibata; Friederike C von Lintig; W Wang; Stijn Cassenaer; Gerry R Boss; Jeffrey E Green
Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
Oncogene 2001;20(16):2044-9.
2001: C Guo; Shihui Yu; Alan T Davis; Huamin Wang; Jeffrey E Green; Khalil Ahmed
A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells.
The Journal of biological chemistry 2001;276(8):5992-9.
2001: JON WIGGINTON; JW Park; M Eilene Gruys; Howard A Young; Cheryl Jorcyk; Timothy C Back; MJ Brunda; R M Strieter; J Ward; Jeffrey E Green; Robert Wiltrout
Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(2):1156-68.
2001: MA Shibata; K Yoshidome; E Shibata; Cheryl Jorcyk; Jeffrey E Green
Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21.
Cancer gene therapy 2001;8(1):23-35.
2000: K Yoshidome; MA Shibata; Christine Couldrey; K S Korach; Jeffrey E Green
Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Cancer research 2000;60(24):6901-10.
2000: K Wu; Heung Tae Kim; J L Rodriquez; Debbie Munoz-Medellin; Syed K Mohsin; Susan G Hilsenbeck; William W Lamph; Marco Gottardis; M A Shirley; John Kuhn; Jeffrey E Green; Powel H Brown
9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3696-704.
2000: Yumi Yokoyama; Jeffrey E Green; Vikas P Sukhatme; Sundaram Ramakrishnan
Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model.
Cancer research 2000;60(16):4362-5.
2000: Ki-Baik Hahm; YH Im; Chan Lee; W Tony Parks; Yung-Jue Bang; Jeffrey E Green; Seong-Jin Kim
Loss of TGF-beta signaling contributes to autoimmune pancreatitis.
The Journal of clinical investigation 2000;105(8):1057-65.
2000: Jeffrey E Green; MA Shibata; K Yoshidome; ML Liu; Cheryl Jorcyk; Miriam R Anver; JON WIGGINTON; Robert Wiltrout; E Shibata; Stanislaw J Kaczmarczyk; W Wang; Z Y Liu; Alfonso Calvo; Christine Couldrey
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Oncogene 2000;19(8):1020-7.
2000: Robert Cardiff; Miriam R Anver; barry gusterson; L Hennighausen; R A Jensen; M J Merino; S Rehm; J Russo; F A Tavassoli; L M Wakefield; J M Ward; Jeffrey E Green
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
Oncogene 2000;19(8):968-88.
2000: Christine Couldrey; Jeffrey E Green
Metastases: the glycan connection.
Breast cancer research : BCR 2000;2(5):321-3.
1999: IG Maroulakou; MA Shibata; Miriam R Anver; Cheryl Jorcyk; M l Liu; N Roche; Anita B Roberts; Ilan Tsarfaty; J Reseau; J Ward; Jeffrey E Green
Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.
Oncogene 1999;18(39):5435-47.
1999: Shihui Yu; Alan T Davis; C Guo; Jeffrey E Green; Khalil Ahmed
Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits.
Journal of cellular biochemistry 1999;74(1):127-34.
1999: MA Shibata; ML Liu; M C Knudson; E Shibata; K Yoshidome; T Bandey; S J Korsmeyer; Jeffrey E Green
Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
The EMBO journal 1999;18(10):2692-701.
1998: ML Liu; Friederike C von Lintig; Marek Liyanage; MA Shibata; Cheryl Jorcyk; Thomas Ried; Gerry R Boss; Jeffrey E Green
Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.
Oncogene 1998;17(18):2403-11.
1998: Jeffrey E Green; N M Greenberg; C L Ashendel; J C Barrett; C Boone; Robert H Getzenberg; J Henkin; R Matusik; T J Janus; Howard I Scher
Workgroup 3: transgenic and reconstitution models of prostate cancer.
The Prostate 1998;36(1):59-63.
1998: K Yoshidome; MA Shibata; IG Maroulakou; ML Liu; Cheryl Jorcyk; L G Gold; V N Welch; Jeffrey E Green
Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.
International journal of oncology 1998;12(2):449-53.
1998: MA Shibata; Cheryl Jorcyk; ML Liu; K Yoshidome; L G Gold; Jeffrey E Green
The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
Toxicologic pathology 1998;26(1):177-82.
1998: MA Shibata; Cheryl Jorcyk; D E Devor; K Yoshidome; S Rulong; James Resau; N Roche; Anita B Roberts; Jerrold M Ward; Jeffrey E Green
Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.
Carcinogenesis 1998;19(1):195-205.
1998: Cheryl Jorcyk; ML Liu; MA Shibata; IG Maroulakou; Kristin L Komschlies; M J McPhaul; James Resau; Jeffrey E Green
Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix.
The Prostate 1998;34(1):10-22.
1997: IG Maroulakou; MA Shibata; Cheryl Jorcyk; X X Chen; Jeffrey E Green
Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice.
Molecular carcinogenesis 1997;20(2):168-74.
1997: Cheryl Jorcyk; L J Garrett; IG Maroulakou; Dennis Watson; Jeffrey E Green
Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron I.
Cellular and molecular biology (Noisy-le-Grand, France) 1997;43(2):211-25.
1997: M A Shibata; Jerrold M Ward; Jeffrey E Green; G Merlino
Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Molecular carcinogenesis 1997;18(3):160-70.
1996: MA Shibata; J M Ward; D E Devor; ML Liu; Jeffrey E Green
Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
Cancer research 1996;56(21):4894-903.
1996: JON WIGGINTON; Kristin L Komschlies; Jeffrey E Green; G W Cox; Cheryl Jorcyk; T C Back; J L Franco; M J Brunda; Robert Wiltrout
Evaluation of the antitumor activity of the interleukin-12/pulse interleukin-2 combination.
Annals of the New York Academy of Sciences 1996;795():434-9.
1996: MA Shibata; IG Maroulakou; Cheryl Jorcyk; L G Gold; Jerrold M Ward; Jeffrey E Green
p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
Cancer research 1996;56(13):2998-3003.
1996: S L Chen; IG Maroulakou; Jeffrey E Green; vincenzo romano spica; W Modi; J Lautenberger; N K Bhat
Isolation and characterization of a novel gene expressed in multiple cancers.
Oncogene 1996;12(4):741-51.
1996: Mee Kyeong Byeon; M A Westerman; IG Maroulakou; Kelly W Henderson; S Suster; Xian-Kui John Zhang; TS Papas; Jana Vesely; M C Willingham; Jeffrey E Green; Clifford W Schweinfest
The down-regulated in adenoma (DRA) gene encodes an intestine-specific membrane glycoprotein.
Oncogene 1996;12(2):387-96.
1995: R Stokes Peebles; C R Maliszewski; T A Sato; J Hanley-Hyde; IG Maroulakou; R Hunziker; Jonathan P Schneck; Jeffrey E Green
Abnormal B-cell function in HTLV-I-tax transgenic mice.
Oncogene 1995;10(6):1045-51.
1995: D K Pokholok; IG Maroulakou; Dmitry V Kuprash; Marat B Alimzhanov; S V Kozlov; Tatiana I Novobrantseva; Regina L Turetskaya; Jeffrey E Green; Sergei A Nedospasov
Cloning and expression analysis of the murine lymphotoxin beta gene.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(3):674-8.
1994: IG Maroulakou; Miriam R Anver; L Garrett; Jeffrey E Green
Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(23):11236-40.
1994: IG Maroulakou; TS Papas; Jeffrey E Green
Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.
Oncogene 1994;9(6):1551-65.
1992: Jeffrey E Green; A M Baird; S H Hinrichs; G K Klintworth; G Jay
Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.
The American journal of pathology 1992;140(6):1401-10.
1991: Jeffrey E Green
trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene.
Molecular and cellular biology 1991;11(9):4635-41.
1989: Jeffrey E Green; C Glenn Begley; D K Wagner; Thomas Waldmann; G Jay
trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene.
Molecular and cellular biology 1989;9(11):4731-7.
1989: Jeffrey E Green; S H Hinrichs; J Vogel; G Jay
Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.
Nature 1989;341(6237):72-4.
1989: Sherri J Bale; Allen E Bale; K Stewart; L Dachowski; O W McBride; Thomas M Glaser; Jeffrey E Green; J J Mulvihill; M L Brandi; Kazuyasu Sakaguchi
Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11.
Genomics 1989;4(3):320-2.
1988: Stephen J Marx; Kazuyasu Sakaguchi; Jeffrey E Green; G D Aurbach; Maria Luisa Brandi
Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1.
The Journal of clinical endocrinology and metabolism 1988;67(1):149-53.